Evidence map›Paper›PMID 24227656›Full record

ArticleDevelopment (Cambridge, England)2013

N-glycosylation requirements in neuromuscular synaptogenesis.

William Parkinson, Mary Lynn Dear, Emma Rushton, Kendal Broadie

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Glycan-related genes and genetic disorders.Journal of human genetics · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. COG7 deficiency inJournal of cell science · 2017
    Article
  18. Article
  19. Article
  20. Molecular Chaperone Calnexin Regulates the Function ofFrontiers in molecular neuroscience · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

William ParkinsonDepartment of Biological Sciences, Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, TN 37212, USA.
Mary Lynn Dear
Emma Rushton
Kendal Broadie
John F. Kennedy Center for the Performing Arts · USVanderbilt University · US

Funding

Genetic Analysis of Synapse Formation and FunctionR01MH096832 · NIMH · VANDERBILT UNIVERSITY · PI BROADIE, KENDAL · 2012 to 2016
$2.3M
N-Linked Glycan Modification in Synaptic Development and FunctionF31NS084622 · NINDS · VANDERBILT UNIVERSITY · PI PARKINSON, WILLIAM M. · 2013 to 2015
$73k
NIMH NIH HHS R01 MH096832NINDS NIH HHS F31 NS084622
6 · The paper itself

Abstract

Neural development requires N-glycosylation regulation of intercellular signaling, but the requirements in synaptogenesis have not been well tested. All complex and hybrid N-glycosylation requires MGAT1 (UDP-GlcNAc:α-3-D-mannoside-β1,2-N-acetylglucosaminyl-transferase I) function, and Mgat1 nulls are the most compromised N-glycosylation condition that survive long enough to permit synaptogenesis studies. At the Drosophila neuromuscular junction (NMJ), Mgat1 mutants display selective loss of lectin-defined carbohydrates in the extracellular synaptomatrix, and an accompanying accumulation of the secreted endogenous Mind the gap (MTG) lectin, a key synaptogenesis regulator. Null Mgat1 mutants exhibit strongly overelaborated synaptic structural development, consistent with inhibitory roles for complex/hybrid N-glycans in morphological synaptogenesis, and strengthened functional synapse differentiation, consistent with synaptogenic MTG functions. Synapse molecular composition is surprisingly selectively altered, with decreases in presynaptic active zone Bruchpilot (BRP) and postsynaptic Glutamate receptor subtype B (GLURIIB), but no detectable change in a wide range of other synaptic components. Synaptogenesis is driven by bidirectional trans-synaptic signals that traverse the glycan-rich synaptomatrix, and Mgat1 mutation disrupts both anterograde and retrograde signals, consistent with MTG regulation of trans-synaptic signaling. Downstream of intercellular signaling, pre- and postsynaptic scaffolds are recruited to drive synaptogenesis, and Mgat1 mutants exhibit loss of both classic Discs large 1 (DLG1) and newly defined Lethal (2) giant larvae [L(2)GL] scaffolds. We conclude that MGAT1-dependent N-glycosylation shapes the synaptomatrix carbohydrate environment and endogenous lectin localization within this domain, to modulate retention of trans-synaptic signaling ligands driving synaptic scaffold recruitment during synaptogenesis.

Indexed as

NeurogenesisAnimalsAnimals, Genetically ModifiedCarrier ProteinsDrosophila melanogasterDrosophila ProteinsGlycosylationN-AcetylglucosaminyltransferasesNervous SystemNeuromuscular JunctionReceptors, AMPASignal TransductionSynapsesSynaptic TransmissionTumor Suppressor ProteinsBRP protein, DrosophilaCarrier Proteinsdlg1 protein, DrosophilaDrosophila Proteinsglutamate receptor type Bl(2)gl protein, DrosophilaMGAT1 protein, Drosophilamtg protein, DrosophilaN-AcetylglucosaminyltransferasesReceptors, AMPATumor Suppressor ProteinsActive zoneDrosophilaGlutamate receptorNeuromuscular junctionSynaptic scaffoldSynaptomatrixTrans-synaptic signaling

Identifiers

PMID24227656
PMCPMC3848190
OpenAlexW2125060394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.